Media Centre
Latest press releases
-
Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with immunoglobulin A nephropathy in I CAN Phase III trial
-
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
-
Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases
-
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial
-
Efzimfotase alfa demonstrated positive results from global Phase III clinical programme in hypophosphatasia
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
